A few days ago, Li Xingqian, director of the Foreign Trade Department of the Ministry of Commerce, said that China exported more than 1 billion masks in a single day, and the Chinese government will never let go of unqualified epidemic prevention materials.
On the 26th, at the press conference of the Joint Prevention and Control Mechanism of the State Council under the theme of “Strengthening the Export Quality Supervision of Medical Materials”, the Ministry of Commerce, the General Administration of Customs, and the General Administration of Market Supervision jointly introduced the recent export of China’s national defense epidemic materials and made recommendations on related issues. Out of response.
At the meeting, Li Xingqian said, “Whether China will restrict the export of anti-epidemic materials”: “China has never restricted the export of anti-epidemic materials, but has tried to find ways to facilitate and support the procurement of countries around the world.” According to statistics from the Ministry of Commerce, as of 4 On May 25, 74 countries and regions and 6 international organizations signed 192 batches of commercial procurement contracts for medical supplies with China, with a cumulative amount of US $ 1.41 billion. 72 countries and regions and 8 international organizations are carrying out 129 batches of commercial procurement negotiations with Chinese enterprises. China ’s 31 provinces, autonomous regions and municipalities have exported anti-epidemic materials to 191 countries and regions through market-based procurement. At the same time, customs statistics show that the number of Chinese export masks reached 1.06 billion on April 24, a 3.7-fold increase from the 224 million before the implementation of the announcement on March 31.
“The channels for countries to purchase commercial anti-epidemic materials in China are completely unblocked,” Li Xingqian reiterated that we sincerely look forward to the difficulties of people all over the world as soon as possible. The so-called “China restricts exports” is completely misunderstood and misunderstood.
China has been taking action to strictly control the quality of exported anti-epidemic materials. The Ministry of Commerce, the General Administration of Customs, and the State Food and Drug Administration issued Announcement No. 5 on March 31, and Announcement No. 12 on April 25. Li Xingqian said that the two announcements tightened the quality control of medical and non-medical anti-epidemic materials, which is based on the initiative of being highly responsible for the lives and health of people in various countries to ensure that China’s qualified products are more effectively provided to the international market.
Li Xingqian stated that Announcement No. 12 clearly strengthened the supervision measures for non-medical masks, and required exporters and importers to sign a joint statement confirming the relevant quality standards and the responsibilities of both parties. The regulatory objects of Announcement 12 and Announcement 5 are different, but the goals are the same and they are executed simultaneously.
Since the beginning of February, the State Food and Drug Administration has launched a special action to combat the remediation of illegal production of masks and other protective products. Li Yujia, the market inspection commissioner of the Law Enforcement and Inspection Bureau of the General Administration of Market Supervision, said yesterday that this special action is continuing. Wang Shucai, deputy director of the Medical Device Supervision Department of the State Food and Drug Administration, also introduced at the press conference that as of April 24, the local drug regulatory authorities sent a total of 10,307 inspectors to inspect the production of medical devices that have been exported and are ready to be exported. 1,216 companies with a total of 6,435 inspections; 417 batches of products under supervision and random inspection. The State Food and Drug Administration will continue to strengthen the quality and safety management of exported medical devices with relevant departments to ensure product safety, effectiveness, and controllable quality.
In addition, the Chinese Customs is another layer of insurance that strictly controls the quality of exported anti-epidemic materials. Jin Hai, director of the General Operations Department of the General Administration of Customs, said that China Customs has always attached great importance to the work of exporting anti-epidemic materials and has taken effective measures to strengthen the supervision of the export of anti-epidemic materials.